Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time
- PMID: 23340890
- PMCID: PMC3661838
- DOI: 10.2337/dc12-1206
Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time
Abstract
Objective: The risk of cardiovascular death before the age of 40 is 20-fold higher in patients with type 1 diabetes mellitus (T1DM). Endothelial progenitor cells (EPCs) predict cardiovascular morbidity and mortality in patients without diabetes. We hypothesized that EPCs are modified in children with T1DM and are related to characteristics of T1DM such as glycemic control.
Research design and methods: Children (n = 190; 156 T1DM subjects and 34 control subjects) were included in an observational cohort study and matched for age and sex. EPCs were enumerated by flow cytometry at the beginning (cross-sectional) and 1 year later (longitudinal). To analyze changes of variables during the observation, Δ values were calculated.
Results: EPCs were significantly reduced in T1DM children versus control subjects (609 ± 359 vs. 1,165 ± 484, P < 0.001). Multivariate regression modeling revealed that glycated hemoglobin A1c (HbA1c) was the strongest independent predictor of EPCs (β = -0.355, P < 0.001). Overall glycemic control at the beginning and end of study did not differ (7.8 ± 1.2 vs. 7.8 ± 1.2 relative %, P = NS), but we observed individual HbA1c changes of -4.30/+3.10 relative %. The strongest EPC increase was observed in the patients with the most favorable HbA1c lowering during the 1-year follow-up. Accordingly, the strongest EPC decrease was demonstrated in the patients with the strongest HbA1c worsening during the time period.
Conclusions: This is the first prospective study demonstrating diminished EPCs in children with T1DM. The association of better glycemic control with an increase in EPC numbers within 1 year suggests that a reduction of the high cardiovascular disease burden might be mediated likewise.
Figures



Similar articles
-
Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus.Cardiovasc Diabetol. 2011 Dec 20;10:113. doi: 10.1186/1475-2840-10-113. Cardiovasc Diabetol. 2011. PMID: 22185563 Free PMC article.
-
Endothelial dysfunction is related to poor glycemic control in adolescents with type 1 diabetes under 5 years of disease: evidence of metabolic memory.J Clin Endocrinol Metab. 2011 May;96(5):1493-9. doi: 10.1210/jc.2010-2363. Epub 2011 Feb 23. J Clin Endocrinol Metab. 2011. PMID: 21346068
-
Relationship between circulating endothelial progenitor cells and endothelial dysfunction in children with type 1 diabetes: a novel paradigm of early atherosclerosis in high-risk young patients.Eur J Endocrinol. 2013 Jan 17;168(2):153-61. doi: 10.1530/EJE-12-0857. Print 2013 Feb. Eur J Endocrinol. 2013. PMID: 23111589
-
Is Helicobacter pylori infection associated with glycemic control in diabetics?World J Gastroenterol. 2015 May 7;21(17):5407-16. doi: 10.3748/wjg.v21.i17.5407. World J Gastroenterol. 2015. PMID: 25954115 Free PMC article. Review.
-
Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2.Cardiovasc Res. 2011 Jul 1;91(1):9-15. doi: 10.1093/cvr/cvq412. Epub 2010 Dec 24. Cardiovasc Res. 2011. PMID: 21186243 Review.
Cited by
-
Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction.Endocrine. 2015 Jun;49(2):415-21. doi: 10.1007/s12020-014-0478-5. Epub 2014 Nov 20. Endocrine. 2015. PMID: 25411101
-
Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes.Cardiovasc Diabetol. 2017 Feb 23;16(1):27. doi: 10.1186/s12933-017-0503-0. Cardiovasc Diabetol. 2017. PMID: 28231835 Free PMC article. Clinical Trial.
-
Mitochondrial Dysfunction in Endothelial Progenitor Cells: Unraveling Insights from Vascular Endothelial Cells.Biology (Basel). 2024 Jan 23;13(2):70. doi: 10.3390/biology13020070. Biology (Basel). 2024. PMID: 38392289 Free PMC article. Review.
-
Type 1 Diabetes Patients With Different Residual Beta-Cell Function but Similar Age, HBA1c, and Cardiorespiratory Fitness Have Differing Exercise-Induced Angiogenic Cell Mobilisation.Front Endocrinol (Lausanne). 2022 Feb 11;13:797438. doi: 10.3389/fendo.2022.797438. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35222269 Free PMC article.
-
Molecular mechanisms associated with diabetic endothelial-erectile dysfunction.Nat Rev Urol. 2016 May;13(5):266-74. doi: 10.1038/nrurol.2016.23. Epub 2016 Feb 16. Nat Rev Urol. 2016. PMID: 26878803 Review.
References
-
- Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 2006;55:1463–1469 - PubMed
-
- Soedamah-Muthu SS, Fuller JH, Mulnier HE, et al. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 2006;29:798–804 - PubMed
-
- Waernbaum I, Blohmé G, Ostman J, et al. Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden. Diabetologia 2006;49:653–659 - PubMed
-
- Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006;49:298–305 - PubMed
-
- Laing SP, Swerdlow AJ, Slater SD, et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003;46:760–765 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous